Larvol Delta - Inhibikase-Therapeutics-to-Present-Data-from-Phase-11b-study-of-IkT148009-at-the-Movement-Disorders-Society-Congress

IkT-148009 - Inhibikase, Clintrex

https://www.prnewswire.com/news-releases/inhibikase-therapeutics-to-present-data-from-phase-11b-study-of-ikt-148009-at-the-movement-disorders-society-congress-301624344.html

Sep 15, 2022

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next